Product Information |
|
Registration Number |
BR-1388
|
Generic Name |
Meningococcal Group A, C, W-135 and Y Conjugate
Vaccine
|
Brand Name |
Menquadfi
|
Dosage Strength |
Formulation: Each dose (0.5 mL) contains: Neisseria meningitidis group A polysaccharide* .... 10 mcg Neisseria meningitidis group C polysaccharide* .... 10 mcg Neisseria meningitidis group Y polysaccharide* .... 10 mcg Neisseria meningitidis group W-135 polysaccharide* .... 10 mcg *Conjugated to Tetanus Toxoid carrier protein... 55 mcg** **Tetanus Toxoid quantity is approximate and dependent on the polysaccharide to protein ratio for the conjugates in each formulation
|
Dosage Form |
Solution for Injection (IM)
|
Classification |
Prescription Drug (RX)
|
Packaging |
Single dose. 0.5 mL in 2 mL USP Type I glass vial with gray chlorobutyl rubber stopper sealed with aluminum and black plastic flip-off cap (Box of 1's and 5's)
|
Pharmacologic Category |
Vaccines
|
Manufacturer |
Sanofi Pasteur
|
Country of Origin |
United States of America
|
Trader |
N/A
|
Importer |
Sanofi Pasteur, Inc.
|
Distributor |
Zuellig Pharma Corporation
|
Application Type |
Monitored Release
|
Issuance Date |
04 March 2022
|
Expiry Date |
04 March 2027
|